Skip to Content
VaccinesVaccines
  • Correction
  • Open Access

13 January 2023

Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499

,
,
,
,
,
,
,
,
and
1
Department of Otorhinolaryngology, University of Rome “Tor Vergata”, 00100 Rome, Italy
2
Department of Experimental Medicine, University of Rome “Tor Vergata”, 00100 Rome, Italy
3
Department of Occupational Medicine, University of Rome “Tor Vergata”, 00100 Rome, Italy
4
Department of Laboratory Medicine, Tor Vergata University Hospital, 00100 Rome, Italy

Error in Figure

The authors wish to make the following corrections to this paper [1]:
In the original publication, there was a mistake in Figure 2 as published. The same image was mistakenly selected for Figure 2 and Figure 3 during proofreading. The corrected Figure 2 appears below.
Figure 2. Anti-SARS-CoV-2 IgA-S1 and anti-SARS-CoV-2 IgG-RBD in saliva samples. (a) Saliva sample median levels of anti-SARS-CoV-2 IgA-S1 in the three study groups, expressed as COI (Cut off index). (b) Saliva sample median levels of anti-SARS-CoV-2 IgG-RBD in the three study groups, expressed as Binding Antibody Units (BAU/mL). In the COVID-19 group, the red rhombuses represent the hospitalized subjects. Statistical analysis and construction of figures were performed with GraphPad Prism 8 Software (GraphPad Software, San Diego, CA, USA). The D’Agostino and Pearson test, the Shapiro-Wilk normality test, and the Kolmogorov–Smirnov test were used to evaluate non-Gaussian distributions in all of the study populations. The continuous data were displayed as median and range. Non-parametric results were analysed with the Mann–Whitney test. For all results, p < 0.05 was considered statistically significant.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Guerrieri, M.; Francavilla, B.; Fiorelli, D.; Nuccetelli, M.; Passali, F.M.; Coppeta, L.; Somma, G.; Bernardini, S.; Magrini, A.; Di Girolamo, S. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.